Mona
Mona Akmal, Kirkland, WA US
Patent application number | Description | Published |
---|---|---|
20110072354 | SOCIAL NETWORK SERVICE SYNCHRONIZATION - Social network service synchronization techniques are described. In an implementation, a determination is made by a client that a browser has been used to navigate to a website. A prompt is displayed by the client, responsive to the determination, that is selectable to cause data that describes activities that are performable in conjunction with the website to be communicated to a social network service to be stored in conjunction with a user account of the user at the social network service. | 03-24-2011 |
20140289407 | GROUP CO-OWNERSHIP OF INTERNET-ACCESSIBLE RESOURCES - In one embodiment, two separate user accounts may share equal ownership of the same internet-accessible resource | 09-25-2014 |
20140344352 | ACTIVITY INTERNET-ACCESSIBLE DATA STORAGE VIEW THAT SHOWS RECENT AND RELEVANT CONTENT TO THE USER - In one embodiment, an internet-accessible resource service may emphasize a recently accessed data object stored in an internet-accessible data storage | 11-20-2014 |
Mona Akmal, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20120150971 | PRESENTING NOTIFICATIONS OF CONTENT ITEMS SHARED BY SOCIAL NETWORK CONTACTS - Within a social network, a user may establish a set of contacts who share with the user various content items and comments related thereto. However, these content items are often hosted by a content source outside of the social network, and the user may have to transition to the content source to view the content item, and then transition back to the social network to submit a comment. Instead, a device may monitor the social network to record shared content items. When the user requests a presentation of the content source, notifications of the content items hosted by the content source that have been shared with the user, including an identifier of the contact sharing the content item with the user (e.g., a depiction or avatar representation of the contact and a link to a social profile of the contact) may be included in the presentation. | 06-14-2012 |
20120151383 | PRESENTING CONTENT ITEMS SHARED WITHIN SOCIAL NETWORKS - Within a social network, a user may establish a set of contacts who share with the user various content items and comments related thereto. However, these content items are often hosted by a content source outside of the social network, and the user may have to transition to the content source to view the content item, and then transition back to the social network to submit a comment. Instead, a device may monitor the social network to record shared content items. When the user requests a presentation of the content source, the content items hosted by the content source that have been shared with the user may be included in the presentation. The presentation of the content source may also accept comments from the user regarding a content item, and send the comments to the social network where the content item was shared with the user. | 06-14-2012 |
20130132463 | CLIENT APPLICATION FILE ACCESS - One or more techniques and/or systems are disclosed for providing a client application with access to a file based upon a local offline version of the file and/or web online version of the file. That is, a file may be shared/synchronized from a remote source, such as a web storage service. A web online version of the file may be maintained by the web storage service, while local offline versions of the file may be stored at client devices. A sync module comprising knowledge of the local and/or web versions of the file may provide a client application with access to the file based upon the local and/or web version of the file. The sync module may also delegate synchronization authorization to the client application given that the client application may comprise sophisticated file handling functionality. | 05-23-2013 |
20160028782 | PRESENTING CONTENT ITEMS SHARED WITHIN SOCIAL NETWORKS - Within a social network, a user may establish a set of contacts who share with the user various content items and comments related thereto. However, these content items are often hosted by a content source outside of the social network, and the user may have to transition to the content source to view the content item, and then transition back to the social network to submit a comment. Instead, a device may monitor the social network to record shared content items. When the user requests a presentation of the content source, the content items hosted by the content source that have been shared with the user may be included in the presentation. The presentation of the content source may also accept comments from the user regarding a content item, and send the comments to the social network where the content item was shared with the user. | 01-28-2016 |
Mona Alinejad, London GB
Patent application number | Description | Published |
---|---|---|
20120184966 | SURGICAL IMPACTOR - A surgical impactor ( | 07-19-2012 |
20120323249 | DRILL GUIDE - A drill guide comprising: a body comprising a hole extending therethrough for guiding a drill; and an alignment tool, the alignment tool being operable to connect the body to an intramedullary rod, such that the orientation of the body is fixable with respect to the intramedullary rod in an anteroposterior plane and in a transverse plane. | 12-20-2012 |
20150066034 | ROTARY MILL - A rotary mill is disclosed comprising a body portion ( | 03-05-2015 |
Mona Alinejad, Oxford GB
Patent application number | Description | Published |
---|---|---|
20160120639 | LIGAMENT FIXING AND A METHOD OF ATTACHING A LIGAMENT - An artificial ligament is provided having an elongate body and two ends, with a loop being provided at least one of the ends and a loop liner being provided within the loop. A kit of artificial ligaments is also provided with each ligament in the kit having a different fixed length. Also provided are methods for determining a length of artificial ligament to be used within a prosthetic knee joint, selecting a ligament from a range or kit of ligaments, and implanting a prosthetic knee joint assembly comprising an artificial ligament. | 05-05-2016 |
Mona Attariyan, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20120185499 | Scalable Package Management For Virtual-Machine Images - A method for managing a virtual machine image includes receiving a request to change a package configuration of a machine, processing an image action received in the request, wherein the processing the image action received includes, opening the image action with associated action inputs, comparing the opened image action inputs with inputs associated with action instances in a database, determining whether the compared opened image action inputs match the inputs associated with action instances, retrieving from the database, image difference data associated with the image action responsive to determining that the compared opened image action inputs match the inputs associated with action instances in the database, and applying the image difference data to an image to transform the image, determining whether each image action in the request has been processed and processing a second image action responsive to determining that each image action has not been processed. | 07-19-2012 |
Mona Boules, Jacksonville, FL US
Patent application number | Description | Published |
---|---|---|
20100173849 | NEO-TRYPTOPHAN - Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77. | 07-08-2010 |
20110183885 | NEO-TRYPTOPHAN - Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77. | 07-28-2011 |
20120108519 | NEO-TRYPTOPHAN - Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77. | 05-03-2012 |
20130210740 | NEO-TRYPTOPHAN - Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77. | 08-15-2013 |
Mona Dehshid, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20150238018 | BODY SUPPORT BRIDGE - A body support bridge comprising a four panel hinged device with top plate capable of adjustable flexed mounting into a generally arched shape from a folded flat configuration. A top plate and front plate are covered with foam. A hinged adjustment plate engaged against adjustment tabs lifts and flexes the top plate into at least four different height levels for multiple functions, including lumbar support positioned between a user's back and the seat, thigh support positioned on a seat behind a user's knee, a foot rest with the device placed on the floor, and a head rest positioned with the front plate placed on a tray table. | 08-27-2015 |
Mona Dvir-Ginzberg, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20100145470 | SCAFFOLDING FOR TISSUE REGENERATION OR REPAIR - The present invention relates to bioresorbable scaffolding for tissue regeneration or repair. The present invention describes an epithelial organoid comprising an aggregate of epithelial cells predominantly expressing markers associated with differentiated cell types, and an aggregate which assumes a structure or performs a function associated with an epithelial organ or a fragment thereof. The present invention also provides a method of treating a subject in need of repair or replacement of an organ or a portion thereof; and/or a method of treating a subject with a disease or disorder which impairs or abrogates a liver, kidney, pancreas, thyroid or pituitary function. The present invention also describes an epithelial graft or artificial organ comprising spheroids, organoids or a combination thereof, and a kit for implantable epithelial graft formation comprising organoids. | 06-10-2010 |
Mona Ezzelarab, Helsingborg SE
Patent application number | Description | Published |
---|---|---|
20130200304 | ACTIVE OXYGEN SOURCE - The present invention relates to a solid active oxygen source coated with a composition comprising at least one polymer, wherein the composition on the oxygen source has been subjected to heating. Said oxygen source is chosen from percarbonates and said polymer is a hydrophobic alkyl cellulose, preferably ethyl cellulose. In a further aspect the present invention relates to a process for the production of a coated active oxygen source, wherein said oxygen source is in solid state and is formed into or in the shape of a granule, and wherein the coating is applied onto the oxygen source and subjected to heating by an application-drying process. | 08-08-2013 |
Mona Ezzelarab, Lund SE
Patent application number | Description | Published |
---|---|---|
20090095472 | WELL TREATMENT FLUID COMPOSITIONS AND METHODS OF USE THAT INCLUDE A DELAYED RELEASE PERCARBONATE FORMULATION - A well treatment fluid and method of use includes water, at least one hydratable polymer, an optional crosslinking agent, and a delayed release percarbonate formulation effective to reduce initial viscosity of the fluid after a period of time. Also disclosed are processes for fracturing a subterranean formation. | 04-16-2009 |
20100248998 | PROCESS FOR THE PRODUCTION OF A GRANULE OF A COATED OXIDIZING COMPOUND SUCH GRANULE AND USES OF THE GRANULE - The invention provides a process for the production of a granule of a coated oxidizing compound which granule has good delayed release properties, said process comprising a) providing cores of an oxidizing compound produced by fluidized bed spray granulation, b) spraying on the oxidizing compound cores an aqueous solution of metal sili-cate in a fluidized bed, said aqueous solution comprising at least 15% by weight metal silicate, and c) drying to form a metal silicate coating layer on the oxidizing compound core, provided that the amount of metal silicate coating layer is at least 8%, preferably at least 10% by weight based on the total weight of the granule. The invention also provides such granule and well treatment fluids including such granule, and processes for use. | 09-30-2010 |
20110278008 | WELL TREATMENT FLUID COMPOSITIONS AND METHODS OF USE THAT INCLUDE A DELAYED RELEASE PERCARBONATE FORMULATION - A well treatment fluid and method of use includes water, at least one hydratable polymer, an optional crosslinking agent, and a delayed release percarbonate formulation effective to reduce initial viscosity of the fluid after a period of time. Also disclosed are processes for fracturing a subterranean formation. | 11-17-2011 |
20130165352 | Well Treatment Fluid Compositions and Methods of Use That Include a Delayed Release Percarbonate Formulation - A well treatment fluid and method of use includes water, at least one hydratable polymer, an optional crosslinking agent, and a delayed release percarbonate formulation effective to reduce initial viscosity of the fluid after a period of time. Also disclosed are processes for fracturing a subterranean formation. | 06-27-2013 |
Mona Frommert, Munich DE
Patent application number | Description | Published |
---|---|---|
20150278471 | SIMULATION OF OBJECTS IN AN ATLAS AND REGISTRATION OF PATIENT DATA CONTAINING A SPECIFIC STRUCTURE TO ATLAS DATA - A data processing method for registering patient data containing normal patient data and specific object data to atlas data not containing this specific object data, the method comprising the following steps performed by a computer: a) acquiring the patient data which comprises anatomical information of the patient including normal patient data and the specific object data of the patient; b) segmenting the specific object data in the patient data; c) acquiring atlas data; d) acquiring meta-information about components of the atlas data; e) performing a fusion of the acquired patient data excluding the segmented specific object data and the atlas data to obtain registered atlas data; and f) simulating the growth of a simulated specific object within the registered atlas data using the registered atlas data and the meta-information about components of the atlas data being adjacent to the area of the specific object to obtain registered atlas data containing a simulated grown specific object. | 10-01-2015 |
Mona Golombiewski, Luneburg DE
Patent application number | Description | Published |
---|---|---|
20080221165 | Use of Octenidine Dihydrochloride in Semisolid Preparations - The invention relates to the use of octenidine dihydrochloride for manufacturing a semisolid pharmaceutical composition for the treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens, where the composition comprises from 0.005 to 5% by weight octenidine dihydrochloride, and a corresponding composition. | 09-11-2008 |
20080254084 | Antimicrobial Preparations Having a Content of Octenidine Dihydrochloride Encapsulated in Liposomes - The invention relates to antimicrobial preparations which comprise octenidine dihydrochloride in liposomes. The invention additionally relates to a process for manufacturing the preparations and to the use of phospholipids for manufacturing antimicrobial preparations which comprise octenidine dihydrochloride. The preparations show a low cytoxicity. | 10-16-2008 |
20110003857 | STABILIZED, ANTIMICROBIALLY EFFECTIVE COMPOSITION WITH A CONTENT OF BISPYRIDINIUM ALKANE - An aqueous-based composition which includes a) at least one bispyridinium alkane (for example octenidine) and b) at least one stabilizer selected from antioxidants, complexing agents, reducing agents, UV filters and photoprotective agents, in particular α-tocopherol, and BHT. The composition can also include c) one or more auxiliaries selected from, for example, nonionic surfactants, ethers, solvents and polymers, in particular fatty alcohol alkoxylates and alkoxylated fatty acid monoglycerides. The presence of the stabilizer reduces or prevents the appearance of decomposition products of bispyridinium alkanes and, in the case of the presence of auxiliaries, of decomposition products of the auxiliaries, such as ethers and peroxides. | 01-06-2011 |
20110092543 | Wound And Mucosa Antiseptic Based on Bispyridiniumalkanes - The invention relates to an antimicrobially effective composition which comprises a) 0.001 to 1% by weight of bispyridiniumalkane, b) humectant and c) water. The composition has an osmolality of from 230 to 350 mOsmol/kg and is free from surfactant. It is used as wound and mucosa antiseptic. | 04-21-2011 |
20120004593 | ANTISEPTIC BASED ON BISPYRIDINIUM ALKANES - An antimicrobially effective composition includes a) at least 0.15% by weight of bispyridinium alkane, b) at least 3.5% by weight of humectant and c) water. Upon dilution with water, the composition produces a solution with an osmolality of from 230 to 350 mOsmol/kg and is free from surfactant. It is used as an antiseptic and is suitable for use in a method for the disinfection of injured or uninjured skin of a human being or animal, preference being given to use in the case of newborns, in particular those born prematurely. | 01-05-2012 |
Mona Goomansingh, Toronto CA
Patent application number | Description | Published |
---|---|---|
20150105036 | MOBILE DEVICE OPERATING MODE ALTERATION - A mobile device, having at least one messaging system, a user interface element having variable intensity lighting, a frequency alteration module having selectable frequency modes, an operating mode switch and a data processor coupled to the messaging system, the user interface element, the frequency alteration module and the operating mode switch. The data processor includes at least one software application configured, following the operating mode switch actuation, to adjust the lighting intensity of the user interface element, to change the frequency mode of the frequency alteration module and to provide a customized output. The customized output aggregates the at least one mobile device messaging system. | 04-16-2015 |
Mona Hahn, Luneburg DE
Patent application number | Description | Published |
---|---|---|
20150335757 | COLOURED DISINFECTANT PREPARATION BASED ON BISPYRIDINIUMALKANE - The non-solid disinfectant preparation includes a) bispyridiniumalkane (in particular octenidine) and b) dye selected from xanthene dyes, azo dyes and polyterpene compounds. The preparation is free from fluorescein and salts thereof. The novel preparations exhibit an excellent remanence effect. | 11-26-2015 |
Mona Jarrahi, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20140346357 | PHOTOCONDUCTIVE DEVICE WITH PLASMONIC ELECTRODES - A photoconductive device that includes a semiconductor substrate, an antenna assembly, and a photoconductive assembly with one or more plasmonic contact electrodes. The photoconductive assembly can be provided with plasmonic contact electrodes that are arranged on the semiconductor substrate in a manner that improves the quantum efficiency of the photoconductive device by plasmonically enhancing the pump absorption into the photo-absorbing regions of semiconductor substrate. In one exemplary embodiment, the photoconductive device is arranged as a photoconductive source and is pumped at telecom pump wavelengths (e.g., 1.0-1.6 μm) and produces milliwatt-range power levels in the terahertz (THz) frequency range. | 11-27-2014 |
Mona Johansson, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100041644 | STABILIZED SOLID PHARMACEUTICAL COMPOSITION OF CANDESARTAN CILEXETIL - The present invention relates to a solid pharmaceutical composition containing candesartan cilexetil as active ingredient and a stabilizing agent selected from the group consisting of esters of saturated fatty acids and monohydroxy alcohols, esters of hydroxycarboxylic acids and monohydroxy alcohols, ethers of C | 02-18-2010 |
Mona Kulkarna, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20140329947 | HYBRID SEALANT COMPOSITION - An acrylic-polyurethane hybrid sealant composition is provided with desirable physical and mechanical properties such as superior adhesion, tensile strength, rheology and bond strength. In particular, the sealant composition of the invention is formulated with isocyanate modified acrylic polymer The composition includes an acrylic pre-polymer, an isocyante functional monomer, a triacrylate as a cross-linker, and a catalyst. A process for preparing the composition is also provided. The hybrid sealant composition is well suited for sealing and bonding requirements in fabrication of articles such as window glazing, back bedding, construction, aerospace and appliances industries. A hybrid sealant composition is provided that develops adequate adhesion and bond strength equivalent to commercially available sealants when used in sealing and bonding applications and is readily formulated to be self- leveling. Articles so fabricated using the hybrid sealant composition are also provided. | 11-06-2014 |
Mona Mcalarney, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090148486 | COMPOSITIONS AND METHODS FOR TREATING PULP INFLAMMATIONS CAUSED BY INFECTION OR TRAUMA - The present disclosed subject matter relates to methods and compositions for restoring a diseased or damaged tooth such that infection is inhibited or eliminated and pulp regeneration is facilitated. The disclosed subject matter also includes a composition comprising a physiologically acceptable matrix seeded with pulp cells. The matrix can be capable of being injected into the pulp chamber of a tooth. In some embodiments, the matrix of a composition includes a hydrogel (e.g., collagen, chitosan, alginate, MATRIGEL™, gelatin, JELL-O®, fibrin), a mesh (e.g., polylactide-coglycolide (PLGA) mesh, polylactide (PLA) mesh, or polyglycolide (PGA) mesh, a cross-linked fiber mesh, a nanofiber mesh, a mesh fabric, biodegradable polymer mesh), a microsphere (biodegradable polymer microsphere, a hydrogel microsphere), or a combination of any of the foregoing. In yet other embodiments, the matrix includes a nanofiber, an artificial three-dimensional scaffold material, or a synthetic three-dimensional scaffold material. | 06-11-2009 |
Mona Mojdeh, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20150063349 | Programmable switching engine with storage, analytic and processing capabilities - An improvement to the prior-art extends an intelligent solution beyond simple IP packet switching. It intersects with computing, analytics, storage and performs delivery diversity in an efficient intelligent manner. A flexible programmable network is enabled that can store, time shift, deliver, process, analyze, map, optimize and switch flows at hardware speed. Multi-layer functions are enabled in the same node by scaling for diversified data delivery, scheduling, storing, and processing at much lower cost to enable multi-dimensional optimization options and time shift delivery, protocol optimization, traffic profiling, load balancing, and traffic classification and traffic engineering. An integrated high performance flexible switching fabric has integrated computing, memory storage, programmable control, integrated self-organizing flow control and switching. | 03-05-2015 |
Mona Møller, Porsgrunn NO
Patent application number | Description | Published |
---|---|---|
20110105721 | PEPTIDES - Isolated peptides that are fragments of protein products arising from frameshift mutations in genes associated with cancer are disclosed. The isolated peptides of the invention are capable of eliciting T cell immunity against cells harboring genes with such frameshift mutations. Cancer vaccines and therapeutically effective compositions containing the peptides of the inventions are also described. | 05-05-2011 |
20120269858 | POLYPEPTIDES - The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes capable of recognising and destroying tumour cells, and pharmaceutical compositions for the treatment, prophylaxis or diagnosis of cancer. | 10-25-2012 |
Mona Patel, Maywood, NJ US
Patent application number | Description | Published |
---|---|---|
20140012553 | SYSTEMS AND METHODS FOR AGGREGATING AND EVALUATING ENVIRONMENTAL DATA - Various embodiments of the present invention are directed to an environmental impact analysis system configured for providing a graphical user interface for displaying a plurality of user consumption inquiries soliciting user input relating to user consumption of one or more resources; receiving user input comprising user consumption data responsive to one or more of the user consumption inquiries; displaying one or more impact reduction goals representing potential user actions that would result in a lesser environmental footprint; and receiving user input comprising goal completion data indicating user completion of one or more of the impact reduction goals. Various embodiments of the system are further configured to determine user impact values indicative of the environmental footprint resulting from user consumption of the one or more resources, and to determine revised user impact values indicative of the user's reduced environmental footprint due to completed impact reduction goals. | 01-09-2014 |
Mona Patel, Belle Mead, NJ US
Patent application number | Description | Published |
---|---|---|
20090099104 | SUBSTITUTED INDAZOLES-O- GLUCOSIDES - Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed. | 04-16-2009 |
20090105164 | SUBSTITUTED INDOLE-O-GLUCOSIDES - Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed. | 04-23-2009 |
20090202525 | DIHYDROISOINDOLONES AS ALLOSTERIC MODULATORS OF GLUCOKINASE - The present invention relates to compounds of Formula (1), | 08-13-2009 |
20100009900 | SUBSTITUTED INDOLE-O-GLUCOSIDES - Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed. | 01-14-2010 |
20100062971 | SUBSTITUTED INDAZOLE-O-GLUCOSIDES - Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed. | 03-11-2010 |
Mona Qureshi-Hart US
Patent application number | Description | Published |
---|---|---|
20150303542 | WIDE TUNABLE BAND FILTERS - The present disclosure introduces wide tunable band filters. In one embodiment, a wide tunable band filter apparatus is described. The filter apparatus may include a microstrip patch having a plurality of symmetrical slots etched into the microstrip patch. A plurality of diodes may be coupled to the microstrip patch. Furthermore, two asymmetrical feed lines may be connected to the microstrip patch. Other embodiments are also described. | 10-22-2015 |
Mona Rueppel, Hoechst Im Odenwald DE
Patent application number | Description | Published |
---|---|---|
20090215962 | MULTILAYERED FILM MADE OF (METH)ACRYLATE COPOLYMER AND POLYCARBONATE - The invention relates to a multilayer film encompassing at least one upper layer a) and one middle layer b) composed of (meth)acrylate copolymers, and also a backing layer c) composed of polycarbonate, where the upper layer a) comprises a light stabilizer and is composed of a (meth)acrylate copolymer which can form semicompatible mixtures with the polycarbonate of the backing layer c), where a test specimen produced from a mixture composed of 20% by weight of (meth)acrylate copolymer and 80% by weight of polycarbonate has a tensile strain at break of at least 75% (ISO 527-2) at 23° C., the middle layer b) comprises a dye and, where appropriate, a light stabilizer, and is composed of an identical or different (meth)acrylate copolymer which can form semicompatible mixtures with the polycarbonate of the backing layer c), where a test specimen produced from a mixture composed of 20% by weight of (meth)acrylate copolymer and 80% by weight of polycarbonate has a tensile strain at break of at least 75% (ISO 527-2) at 23° C., and the backing layer c) is composed of polycarbonate which can, where appropriate, comprise up to 30% by weight of the material of the layers a) and b). The invention also relates to the production and uses of the multilayer film, and also to semicompatible polymer mixtures composed of (meth)acrylate copolymers and polycarbonate. | 08-27-2009 |
Mona Saghafi, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20140287877 | Seated Inversion Chair and Method of Treating Migraine Headaches - An inversion chair and the method of treatment are provided to assist a user in the treatment and prevention of migraine headaches by increasing and altering the blood flow within the head. The inversion chair includes a frame having a first and a second side connected to each other by a fixed backrest. The sides of the frame have L-shaped configurations comprising upstanding side and base sections that are connected by a curved member. A rotatable seat is positioned between the sides of the frame. The chair is adapted to transition between a standard sitting position to an inverted position. The chair comprises an upper user support bar and a lower leg support bar for maintaining a user within the chair during inverted use. The support bar is removable and used to either secure the lap of the individual when inverted, or support the chair when in an upright state. | 09-25-2014 |
Mona Serageldin, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20160125338 | Planning System Using Spatial-Based Visualization Aids - A presentation, organizational and analytical system comprises includes an information database component that allows project specific ability to organize data and observations. A computer system constructs visual overlays of spatially mapped features, quantitative and qualitative attributes and produces an analytical framework where the attributes of any spatial location change in response to changes in the features of a context. | 05-05-2016 |
Mona Shahbazian, Martinez, CA US
Patent application number | Description | Published |
---|---|---|
20120088233 | Method of Preparing Quality Control Material for FFPE - This specification relates to Formalin-fixed embedded quality control material for use for validation, verification, and to run controls for molecular assays. The quality control material can be used for a variety of tissues and for a variety of molecular assays. The quality control material can be used in commercial labs for validation and limit-of-detection analyses. | 04-12-2012 |
20140335533 | Method of Preparing Quality Control Material for FFPE - This specification relates to Formalin-fixed embedded quality control material for use for validation, verification, and to run controls for molecular assays. The quality control material can be used for a variety of tissues and for a variety of molecular assays. The quality control material can be used in commercial labs for validation and limit-of-detection analyses. | 11-13-2014 |
20150133314 | REAGENTS AND METHODS FOR SEQUENCING - The disclosure provides a plurality of nucleic acid sequences comprising multiple variants of a reference sequence. The disclosure further provides plasmids, cells, methods and kits comprising the same. | 05-14-2015 |
Mona Shahbazian, Concord, CA US
Patent application number | Description | Published |
---|---|---|
20090197275 | Controls For Detecting Methicillin Resistant Staphylococcus Aureus (MRSA) - The invention relates to the quality control of | 08-06-2009 |
Mona Sharma, Jabalpur IN
Patent application number | Description | Published |
---|---|---|
20150332135 | SYSTEMS AND METHODS FOR TIME CHANGING DYNAMIC SECURITY CODE - The present technology provides dynamic security code systems and method for their creation and use. The systems include a base layer including a first pattern and a sublimating compound layer including a plurality of materials selectively covering the base layer. In some embodiments, each of the plurality of materials is configured to sublimate at respective sublimation rates. The system further includes a shielding layer configured to shield the base layer and the sublimating compound layer to form a security code. The shielding layer can be configured to control a diffusion rate of the plurality of materials through the shielding layer such that the security code is changed. | 11-19-2015 |
20160054218 | INTRALUMINAL PRESSURE DETECTION FOR DIVERTICULAR DISEASE - A pressure detection tablet is disclosed. The tablet is a capsule including a dye encapsulated within an inner coating, in which the inner coating is configured to rupture at a pressure equal to or greater than a pressure threshold. The tablet further includes an outer coating surrounding the capsule, in which the outer coating is configured to provide delivery of the capsule to a targeted site. The dye may be a non-metabolized, water soluble dye, such that a ruptured capsule releases the dye which can be visually detected in the urine. In some embodiments, the disclosure provides a method of making the tablet, using the tablet to detect peak pressure in the colon and reducing the risk of developing a colonic disorder. | 02-25-2016 |
Mona Skjelland, Oslo NO
Patent application number | Description | Published |
---|---|---|
20100105088 | METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36 - The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed. | 04-29-2010 |
20110212471 | METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36 - The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed. | 09-01-2011 |
20140371089 | METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36 - The present invention relates to diagnosis, classification and monitoring of atherosclerotic plaques in an individual using measurement of the concentration of CD36 in a body fluid and/or the plaque as such. The present invention also relates to diagnosing the burden of atherosclerotic plaques in an individual. Furthermore, the invention relates to a method for diagnosing stenosis caused by atherosclerotic plaques. Within the scope of the present invention are also methods for determining the treatment regime of an individual. Kits and oligonucleotides for use in the methods are claimed. | 12-18-2014 |
Mona Stahle-Backdahl, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20090088382 | Use of the cathelicidin LL-37 and derivatives therof for wound healing - Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37. | 04-02-2009 |
20130287839 | USE OF THE CATHELICIDIN LL-37 AND DERIVATIVES THEREOF FOR WOUND HEALING - Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37. | 10-31-2013 |
20150094256 | USE OF THE CATHELICIDIN LL-37 AND DERIVATIVES THEREOF FOR WOUND HEALING - Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37. | 04-02-2015 |
Mona Ståhle-Bäckdahl, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20110293707 | USE OF THE CATHELICIDIN LL-37 AND DERIVATIVES THEREOF FOR WOUND HEALING - Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37. | 12-01-2011 |
Mona Suryana, Singapore SG
Patent application number | Description | Published |
---|---|---|
20130065794 | PROCESS FOR MAKING AN ARRAY - There is disclosed a method of making an array for cell assays comprising the step of providing an array of structures on a substrate, each of said structures having a pre-defined topography thereon, and wherein at least one structure has a different topography from at least one other structure. | 03-14-2013 |
Mona Syhre, Christchurch NZ
Patent application number | Description | Published |
---|---|---|
20080286830 | Analysing Breath Samples for Volatile Organic Compound - The invention describes the use of a biomarker pentylfuran to detect bacterial and/or fungal pathogens. Pentylfuran is released from certain pathogens and detected in the headspace gas of an in vitro culture or in the breath sample of a patient. Pentylfuran is particularly useful in the detection of | 11-20-2008 |
Mona Tawashi, Los Altos, CA US
Patent application number | Description | Published |
---|---|---|
20130011349 | Topical Formulations Containing Palm Pollen - Compositions are provided that include date palm pollen or an extract thereof. The compositions may be formulated for topical use in methods of treatment or prophylaxis of various skin conditions or methods to counteract the effects of skin aging. | 01-10-2013 |
20150352170 | Palm Pollen for Treatment of Mucositis and Inflammatory Conditions - Compositions are provided that include date palm pollen or an extract thereof. The compositions may be formulated use in methods of treatment or prophylaxis of inflammatory conditions such as adverse side effects of anti-cancer treatment or stomatitis conditions. | 12-10-2015 |
Mona Widhe, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20130115698 | METHODS AND COMBINATION - A method and a combination for the cultivation of eukaryotic cells are provided, as well as a method for preparation of eukaryotic cells. The methods comprise providing a sample of eukaryotic cells to be cultured, applying said sample to a cell scaffold material; and maintaining said cell scaffold material having cells applied thereto under conditions suitable for cell culture. The combination comprises eukaryotic cells and a cell scaffold material. The cell scaffold material comprises a polymer of a spider silk protein. | 05-09-2013 |
20160024464 | METHODS AND COMBINATION COMPRISING EUKARYOTIC CELLS AND RECOMBINANT SPIDER SILK PROTEIN - A method and a combination for the cultivation of eukaryotic cells are provided, as well as a method for preparation of eukaryotic cells. The methods comprise providing a sample of eukaryotic cells to be cultured, applying said sample to a cell scaffold material; and maintaining said cell scaffold material having cells applied thereto under conditions suitable for cell culture. The combination comprises eukaryotic cells and a cell scaffold material. The cell scaffold material comprises a polymer of a spider silk protein. | 01-28-2016 |
Mona Winkvist, Enkoping SE
Patent application number | Description | Published |
---|---|---|
20130089371 | PRE-TENSIONING DEVICE BETWEEN TWO ELEMENTS MOUNTED IN SPACED RELATION ON AN AXLE - A device operative to generate a pre-tension between two elements which are to be mounted in spaced relation on an axle is disclosed. The device includes a first ring ( | 04-11-2013 |
Mona Zebarjadi, East Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20140070167 | Solid State Cloaking for Electrical Charge Carrier Mobility Control - An electrical mobility-controlled material includes a solid state host material having a controllable Fermi energy level and electrical charge carriers with a charge carrier mobility. At least one Fermi level energy at which a peak in charge carrier mobility is to occur is prespecified for the host material. A plurality of particles are distributed in the host material, with at least one particle disposed with an effective mass and a radius that minimize scattering of the electrical charge carriers for the at least one prespecified Fermi level energy of peak charge carrier mobility. The minimized scattering of electrical charge carriers produces the peak charge carrier mobility only at the at least one prespecified Fermi level energy, set by the particle effective mass and radius, the charge carrier mobility being less than the peak charge carrier mobility at Fermi level energies other than the at least one prespecified Fermi level energy. | 03-13-2014 |